Search Media Coverage


To refine your search select a single option or a combination of options:

reset
 

Media Coverage

Displaying Media Coverage item(s) associated with lawyer Bob Steinberg
13 results
 
  • July 24, 2019
     
    Law360
    The US International Trade Commission cleared Latham client Honda of allegations it violated federal import trade law, ending the commission's review of an administrative law judge's determination reaching the same conclusion.
     
    Share
    view
  • April 27, 2018
     
    Law360
    IP litigation partner Bob Steinberg foresees how America Invents Act reviews will be conducted at the US Patent Trial and Appeal Board following two landmark rulings by the U.S. Supreme Court.
     
    Share
    view
  • March 27, 2018
     
    law.com
    Latham IP partner Bob Steinberg recently interviewed the new Director of the US Patent and Trademark Office, Andrei Iancu, at the annual conference of the PTAB Bar Association, which Steinberg helped to found and served as the organization's first President.
     
    Share
    view
  • July 01, 2017
     
    The National Law Journal
    Honored among a select group of intellectual property lawyers for his leadership in patent litigation and at the US Patent Trial and Appeal Board.
     
    Share
    view
  • September 30, 2016
     
    law.com
    Multiple law firms collaborated to form a new bar association dedicated to preserving and promoting the highest professional and ethical standards among lawyers and stakeholders who appear before the Patent Trial and Appeal Board. Latham IP partner Bob Steinberg was elected by his peers to be the organization's first President.
     
    Share
    view
  • May 12, 2016
     
    Law360
    The Patent Trial and Appeal Board invalidated a Delphix Corp. patent asserted against Latham client Actifio Inc., stating that Actifio Inc. had shown the patent can't survive in light of prior art.
     
    Share
    view
  • January 15, 2016
     
    Law360
    The Patent Trial and Appeal Board denied two requests by Amgen for reviews of two AbbVie patents covering the megablockbuster Humira, just months after Amgen had asked the FDA for permission to market a biosimilar version of the autoimmune disease drug.
     
    Share
    view
  • October 12, 2015
     
    Los Angeles Business Journal
    Latham's Diversion band performed at Ketchum-Downtown YMCA's Stair Climb for Los Angeles event.
     
    Share
    view
  • January 30, 2015
     
    Law360
    The firm’s “stable of veteran IP trial attorneys” honored for high-profile patent case wins and strengths across the practice.
     
    Share
    view
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.